← Leaderboards
George N Serbedzija
Phylonix Pharmaceuticals, Inc.
$822,432
Attributed
$822,432
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$822,432 · 5
By mechanism
R43$822,432 · 5
Top collaborators
No co-investigators on record.
Most similar at Phylonix Pharmaceuticals, Inc.
Same institution · by research overlap
- Wen L Seng$5,142,092
- Catherine E Willett$2,861,955
- Chuenlei Parng$2,901,526
- Demian Park$957,438
- Maryann L Haldi$2,524,006
Others in their field
Top investigators on “Zebrafish”
- Leonard I Zon · Children'S Hospital Boston$58,820,730
- Monte Westerfield · University Of Oregon$50,217,878
- Richard A Gibbs · Baylor College Of Medicine$49,965,365
- Karl Alexander Deisseroth · Stanford University$29,745,200
- William S Talbot · Stanford University$29,496,829
- Robert L Tanguay · Oregon State University$27,361,484
Research focus
ZebrafishEmbryo /Fetus CultureDisease /Disorder ModelDrug Screening /EvaluationModel Design /DevelopmentAlternatives To Animals In ResearchAngiogenesisEmbryo /Fetus Drug Adverse EffectNeoplasm /Cancer Blood SupplyTechnology /Technique DevelopmentDrug Adverse EffectWestern BlottingsBioassayHistologyMicroscopyMolecular GeneticsNorthern BlottingsAngiogenesis InhibitorsAntineoplasticsAquacultureApoptosisBiological ModelsCell ProliferationCell Transplantation
Grant awards (5)
Whole Animal Microplate Assay for Angiogenesis$206,599
R43 · FY2001 · CA
Zebrafish: A Whole Animal Model for Target Validation$155,764
R43 · FY2001 · CA
WHOLE ANIMAL ASSAY FOR ANGIOGENESIS INHIBITION$160,535
R43 · FY2000 · CA
WHOLE ANIMAL MODEL FOR HEPATOCELLULAR CARCINOMA$149,800
R43 · FY2000 · CA
WHOLE ANIMAL APOPTOSIS ASSAY FOR CANCER DRUG SCREENING$149,734
R43 · FY2000 · CA